QOL Medical, CEO To Pay $47 Million for Offering Free Lab Tests

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

QOL Medical, CEO To Pay $47 Million To Resolve False Claims Allegations Stemming From Free Lab Tests

Dennis Tosh

November 20, 2024 at 12:17 PM EST

A pharmaceutical company and its CEO and co-owner have agreed to pay $47 million to resolve allegations that they offered illegal kickbacks in the form of free laboratory services to induce health care providers to prescribe a drug manufactured by the firm, leading to violations of the federal False Claims Act and parallel state statutes (United States ex rel. John Doe 1, et a... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

QOL Medical, CEO To Pay $47 Million To Resolve False Claims Allegations Stemming From Free Lab Tests

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT